Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.

Dr. Eric Roselli discusses COVID-19: Early Insights into Cardiovascular Issues.

Level of baseline cardiopulmonary fitness strongly correlates with outcomes of atrial fibrillation ablation. Those that are more fit are more likely to maintain long term sinus rhythm, come off antiarrhythmic medications and have improved mortality. This study reinforces the impact that cardiovascular risk factors such as weight, blood pressure, diabetes, sleep apnea - and now cardiovascular fitness has on atrial fibrillation management.

Dr. Eric Roselli and Dr. Amit Goyal discuss diets and heart health, cardiovascular disease prevention.

Dr. Jay Khatri, Director of the Complex Coronary Interventions presents the definition and presentation of CTO, barriers to initiating PCI in CTO, indications for therapy and advanced skills to implement CTO PCI safely and successfully. Dr. Khatri reviews the algorithm used at Cleveland Clinic to determine CTO management.

Dr. Eric Roselli and Dr. Amit Goyal discuss Management of COVID-19 Related Myocarditis.

Dr. Eric Roselli and Dr. Amit Goyal discuss Thrombotic Complications and Hypercoagulability Associated with COVID-19 Infection.

What happens when an athlete has COVID-19? How does it impact the cardiovascular and cardiopulmonary fitness of the athlete? Dr. Michael Emery and Dr. Tamanna Singh, Co-Directors of the Cleveland Clinic Sports Cardiology Center, discuss the effects of COVID-19 and recommendations for return to sports. Dr. Singh and Dr. Emery highlight the expert analysis paper published by the American College of Cardiology as well as advice they provide their patients regarding return to play.

Dr. Anter talks about his experience working with Dr. Mark Josephson, a pioneer in the field of electrophysiology. He describes the challenges of ventricular tachycardia ablation, particularly in the setting of heart failure, current research addressing these challenges, and his vision for ventricular tachycardia care in the future.

New primary prevention guidelines for women addresses both risk factors unique to women, such as autoimmune disorders and pregnancy related factors, as well as differences in traditional risk factors such as hypertension, diabetes and hyperlipidemia. The new guidelines also covers topics that have been debated over the years such as hormone replacement therapy and aspirin.